SCHEMBL986779

SCHEMBL986779

OC1C=Cc2cccc(Br)c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29034032 0.77 ALDH1A1 (0.35)
SCHEMBL2481117 0.75 ALDH1A1 (0.30)
SCHEMBL2963737 0.72
SCHEMBL2961334 0.69 ALDH1A1 (0.39)
SCHEMBL23360990 0.67 KDM1A (0.31)
SCHEMBL29118184 0.67 KDM1A (0.31)
SCHEMBL29118170 0.67 KDM1A (0.31)
SCHEMBL2957332 0.65 HTR2C (0.35)
SCHEMBL2962529 0.65 KDM1A (0.37)
SCHEMBL23855440 0.64 MEN1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112513110-B Ethylene-propylene linear copolymers as viscosity modifiers 埃克森美孚化学专利公司 2023-10-27 CN disclosed
CN-112513110-A Ethylene-propylene linear copolymers as viscosity modifiers 埃克森美孚化学专利公司 2021-03-16 CN disclosed
CN-112236505-A Ethylene-propylene branched copolymers as viscosity modifiers with enhanced fuel economy 埃克森美孚化学专利公司 2021-01-15 CN disclosed
US-8598355-B2 Amide compound ASTELLAS PHARMA INC. (JP) 2013-12-03 US disclosed
EP-2565191-A1 4-(Indol-7-ylcarbonylaminomethyl)cyclohexanecarboxylic acid derivatives as EP4 receptor antagonists useful for the treatment of chronic renal failure or diabetic nephropathy Astellas Pharma Inc. (JP) 2013-03-06 EP disclosed
US-20110144153-A1 AMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2011-06-16 US disclosed
EP-2277858-A1 AMIDE COMPOUND Astellas Pharma Inc. (JP) 2011-01-26 EP disclosed